0R8U.LSE Pandox AB Series B
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- 2.29%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.
Is 0R8U.LSE undervalued?
Graham numberThe Graham number of Pandox AB Series B cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pandox AB Series B fundamental analysis
No fundamental analysis for Pandox AB Series B yet.
Pandox AB Series B stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pandox AB Series B
Pandox AB (publ) owns, develops, and leases hotel properties to skilled hotel operators under long-term, turnover based leases with minimum guaranteed levels. Since their inception in 1995, they have grown into one of the largest hotel property owners in Europe. Their portfolio consists of 193 hotel properties with approximately 43,000 rooms across 11 countries in Northern Europe. The portfolio market value is approximately SEK 90bn. The headquarters is in Stockholm, and we …
Full company profilePandox AB Series B financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pandox AB Series B annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 3.95B | 4.27B | 5.12B | 5.55B | 3.18B | - | - | - |
| Gross Profit | 1.79B | 2.21B | 2.89B | 3.20B | 1.62B | - | - | - |
| Operating Income | 1.67B | 2.08B | 2.75B | 3.02B | 1.44B | - | - | - |
| Net Income | 2.20B | 3.14B | 2.82B | 2.71B | -1.40B | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 38.4B | 51.7B | 55.0B | 65.8B | 64.8B | - | - | - |
| Total Liabilities | 23.3B | 32.9B | 33.6B | 39.5B | 40.9B | - | - | - |
| Shareholders' Equity | 15.1B | 18.8B | 21.4B | 26.4B | 23.9B | - | - | - |
| Cash & Short-term Investments | 517M | 999M | 674M | 632M | 2.62B | - | - | - |
| Total Debt | 18.3B | 23.6B | 19.5B | 26.6B | 28.9B | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 1.20B | 1.69B | 1.71B | 1.93B | 460M | 430M | 2.38B | - |
| Capital Expenditure | 100M | 128M | 65.0M | 110M | 67.0M | 97.0M | 0.00 | 0.00 |
| Ratios | ||||||||
| ROE | 14.6% | 16.7% | 13.2% | 10.3% | -5.9% | - | - | - |
| ROA | 5.7% | 6.1% | 5.1% | 4.1% | -2.2% | - | - | - |
| Net Profit Margin | 55.8% | 73.6% | 55.0% | 48.7% | -44.0% | - | - | - |
| Debt to Equity | 1.21x | 1.25x | 0.91x | 1.01x | 1.21x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Pandox AB Series B dividends
Pandox AB Series B has not paid dividends in the last 9 fiscal years.
Who owns Pandox AB Series B
- Insiders 11.93%
- Institutions 79.66%
- Public & others 8.42%
- Free float 105M
Pandox AB Series B company profile
- Company name
- Pandox AB Series B
- Ticker
- 0R8U.LSE
- Exchange
- London Exchange
- Sector
- Real Estate
- Industry
- Commercial Services & Supplies
- Employees
- 1,552
- Fiscal year end
- December
- Address
- Vasagatan 11, Stockholm, Sweden, 101 20
- Phone
- 46 8 50 62 05 50
- Website
- pandox.se
About Pandox AB Series B
Pandox AB (publ) owns, develops, and leases hotel properties to skilled hotel operators under long-term, turnover based leases with minimum guaranteed levels. Since their inception in 1995, they have grown into one of the largest hotel property owners in Europe. Their portfolio consists of 193 hotel properties with approximately 43,000 rooms across 11 countries in Northern Europe. The portfolio market value is approximately SEK 90bn. The headquarters is in Stockholm, and we are listed on Nasdaq Stockholm. Pandox AB (publ) was established on January 28, 1932 and incorporated in Sweden. The company was founded in 1932 and is based in Stockholm, Sweden.
Pandox AB Series B management
10- Ms. Liia NouChief Executive Officer · born 1965
- Ms. Anneli LindblomChief Financial Officer · born 1967
- Mr. Anders BergSenior VP & Head of Communications and IR · born 1967
- Mr. Jonas TornerChief Commercial Officer · born 1971
- Mr. Aldert SchaaphokSenior VP & Director of International Operations · born 1959
- Mr. Jacob RasinSenior Vice President of Transactions
- Mr. Martin CreydtSenior VP & Director of Asset Management International · born 1965
- Ms. Caroline TivéusSenior VP & Director of Sustainable Business · born 1979
- Mr. Tobias EkmanSenior VP & Director of Asset Management Nordics · born 1972
- Mr. Josefin BergqvistHead of Valuations